Future Medicines - Statistics

General Stats
  • This quiz has been taken 10 times
    9 since last reset
  • The average score is 12 of 38
Answer Stats
Hint Answer % Correct
IL-1 antagonist for RA anakinra
67%
DMARD inhibitor of calcineurin for RA, UC and organ rejection cyclosporin
67%
Fusion protein of 2 soluble TNFaRs etanercept
67%
Block receptor to prevent aldosterone release, AT1R antagonists losartan
67%
DMARD - dihydrofolate reductase inhibitor to inhibit thymine methotrexate
67%
B-adrenoceptor antagonists to slow heart rate, anti-arrhythmic propanolol
67%
HMG CoA reductase inhibition, increase LDLR expression statins
67%
JAK inhibitor for RA tofacitinib
67%
TNFa inhibitor adalimumab
33%
Inhibitor of PCSK9 alirocumab
33%
DMARD inhibiting purine synthesis azathioprine
33%
Reduce aldosterone production, reduce blood pressure, ACEIs captopril
33%
Loop diuretic specific for pulmonary oedema, prevents salt/water retention furosemide
33%
P2X3 inhibitor on sensory nerves for cough gefapixant
33%
siRNA to inhibit IC synthesis of PCSK9 inclisiran
33%
TNFa inhibitor infliximab
33%
CFTR channel potentiator ivacaftor
33%
Chaperone for CFTR folding, increases CFTR at membrane lumacaftor
33%
What previous is converted into to inhibit amidophosphoribosyltransferase mercaptopurine
33%
DMARD increasing PPARy activation for RA and UC mesalazine
33%
Bound IL-6R inhibitor preventing gp130 binding olamkicept
33%
IL-6 inhibitor to prevent gp130 binding for RA and covid olokizumab
33%
siRNA to interfere with production of apolipoprotein a olpasiran
33%
PDE4 selective inhibitor roflumilast
33%
IL-6 inhibitor for RA sirukumab
33%
CFTR protein folding corrector tezacaftor
33%
IL-6R inhibitor for RA tocilizumab
33%
Stimulates GC in absence of NO increasing renal blood flow, vasodilation vericiguat
33%
IL-5R inhibitor, preventing IL-5 activation of baso/eosinophils benralizumab
0%
SGLT2 inhibitors preventing glucose reabsorption in kidneys, no hr effect dapagliflozin
0%
Anti-oxidant, aiding in protection from free radicals edaravone
0%
PDE3 selective inhibitor enoximone
0%
Non-selective inhibitor of both PDE3 and 4 ensifentrine
0%
Blocks presynaptic Na+ channels to prevent glutamate transmission riluzole
0%
Anti-CD20 antibodies for MS and RA rituximab
0%
Neprilysin inhibitor sacubitril
0%
Aldosterone receptor antagonist reversing left ventricular hypertrophy spironolactone
0%
TSLP (alarmin) inhibitor to reduce expression with allergen presence tezepelumab
0%
No matching quizzes found
Score Distribution
Percent of People with Each Score
Percentile by Number Answered
Your Score History
You have not taken this quiz since the last reset